HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carcinogens In Cosmetics Need Oversight, Environmental Group Claims

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics manufacturers should reformulate products containing known or possible carcinogens and educate consumers on ingredient safety and alternatives to potentially harmful personal care products, according to Environmental Working Group, a non-profit research organization
Advertisement

Related Content

Data Submission To CIR Could Be Limited To Accelerate Reviews
EWG product safety database
CFSAN Reinforcement Of Cosmetic Authority Should Be “A” List In ’06 – CTFA
Cosmetic safety guidance
Cosmetic Industry “Report Card” To Be Released By Advocacy Group
CFSAN 2005 Priorities Include Responding To EWG Petition
CIR Will Seek Trichloroethane Data, FDA Input For Ingredient Review
EWG report
Proposed Calif. Phthalates Ban Revived; Headed To Senate Floor
CIR Hair Dye Safety Reports, Epidemiology Statement Changes Issued
Advertisement
UsernamePublicRestriction

Register

RS012199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel